A randomised comparison of three different immobilisation devices for thoracic and abdominal cancers by Hubie, Catherine et al.
A randomised comparison of three different immobilisation 
devices for thoracic and abdominal cancers
HUBIE, Catherine, SHAW, Maddison, BYDDER, Sean, LANE, Jonny, 
WATERS, Gemma, MCNABB, Megan, KEARVELL, Rachel, CONCANNON, 
Alicia, BHARAT, Chrianna and APPLEYARD, Robert
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/14617/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
HUBIE, Catherine, SHAW, Maddison, BYDDER, Sean, LANE, Jonny, WATERS, 
Gemma, MCNABB, Megan, KEARVELL, Rachel, CONCANNON, Alicia, BHARAT, 
Chrianna and APPLEYARD, Robert (2016). A randomised comparison of three 
different immobilisation devices for thoracic and abdominal cancers. Journal of 
Medical Radiation Sciences. (In Press) 
Repository use policy
Copyright © and Moral Rights for the papers on this site are retained by the 
individual authors and/or other copyright owners. Users may download and/or print 
one copy of any article(s) in SHURA to facilitate their private study or for non-
commercial research. You may not engage in further distribution of the material or 
use it for any profit-making activities or any commercial gain.
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
ORIGINAL ARTICLE
A randomised comparison of three different immobilisation
devices for thoracic and abdominal cancers
Catherine Hubie, MSc, BSc (Hons),1 Maddison Shaw, BAppSc(MedRad),1
Sean Bydder, MBChB, MBA, MPH, FRANZCR,1 Jonny Lane, DiplPEM, MSc, BSc,1
Gemma Waters, BAppSc(MedRad),1 Megan McNabb, BMedRadSc,1
Rachel Kearvell, PgDip (Health Admin), Dip App Sc (RT),1 Alicia Concannon, BMedRadSc,1
Chrianna Bharat, BSc (Hons), 1,2 & Rob Appleyard, MSc, BSc3
1Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
2Centre for Applied Statistics, University Western Australia, Nedlands, Perth, Western Australia, Australia
3Faculty of Health Science, Sheffield Hallam University,Sheffield, UK
Keywords
Abdomen, immobilisation, lung,
radiotherapy
Correspondence
Catherine Hubie, Radiation Oncology, Cancer
Centre, Sir Charles Gairdner Hospital,
Gairdner Drive, Nedlands, Perth, WA 6009,
Australia. Tel: +61 8 3633 3000;
Fax: +61 8 9346 1053;
E-mail: catherine.hubie@health.wa.gov.au
Funding Information
Australian Government, Department of
Health and Ageing, Better Access to
Radiation Oncology Program. Radiation
Oncology, SCGH, Perth.
Received: 15 February 2016; Revised: 4
September 2016; Accepted: 9 September
2016
J Med Radiat Sci xx (2016) xxx–xxx
doi: 10.1002/jmrs.202
Abstract
Introduction: Patient immobilisation is critically important for both highly
conformal conventionally fractionated radiotherapy and for stereotactic body
radiotherapy. Different immobilisation devices are available to maintain patient
position for radiotherapy but the most suitable one remains unknown.
Methods: Forty-five patients were randomly allocated to one of three
immobilisation devices; the Q fix arm shuttle, BodyFIX without wrap or
BodyFIX with wrap. Patients were imaged before and after treatment to
ascertain intra-fraction and inter-fraction motion. Bony anatomy was used for
matching to determine the positional accuracy of each device. Treatments were
timed using a standard method. Patient comfort and staff satisfaction
questionnaires were also issued to determine comfort, ease of use and
preferences for each device. Results: The BodyFIX without wrap was the more
accurate device; however, the differences between the devices were not
statistically significant. The BodyFIX with wrap was found to take significantly
longer to set up and set down compared to the arm shuttle and the BodyFIX
without wrap (all P < 0.001). Patients (37%) marginally preferred the BodyFIX
with wrap. Most (81%) staff preferred the BodyFIX without wrap. Conclusion:
Immobilisation using the BodyFIX without wrap was deemed to be suitable for
clinical use. It was a clinically accurate device, the more efficient in terms of set
up and set down time, the most preferred by staff and was accepted by
patients.
Introduction
Patient immobilisation is important for conventionally
fractionated radiotherapy and stereotactic body
radiotherapy (SBRT).1–6 The risk of a geographical miss
or positioning error for hypo-fractionated techniques can
be greater than with conventional fractionation.1,7–13
There are a number of immobilisation devices available,
with most research being for SBRT, however, even for
this indication unknowns remain. In a survey of Japanese
centres delivering SBRT, rigid immobilisation is used in
most centres, with 11% using the BodyFIX system, 69%
the Elekta stereotactic body frame and 20% using a
combination of other devices, yet they did not compare
the effectiveness of these devices.14,15 Han et al.7
compared the use of the BodyFIX system with wrap, the
BodyFIX Blubag alone and with the abdominal
compression plate (ACP). The results showed a decrease
in motion in all three directions when applying vacuum
pressure using the BodyFIX system, reducing tumour
motion in the superior-to-inferior direction from 6.1 mm
with free breathing to 5.3 mm with the vacuum pressure.
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Winnie et al.4 investigated the effect of performance
status and immobilisation on intra-fraction motion and
treatment time, finding that the evacuated cushion with
abdominal compression was the most consistent, with
73% mid-treatment and 68% post-treatment still being
within a 3 mm tolerance, whereas the chest board alone
had only 58% mid-treatment and 46% post-treatment.
The evacuated cushion with abdominal compression had
the longest treatment time of 32.54  8.07 min. The
authors did not state how this time was achieved,
however, for an SBRT patient this difference is small, but
when using conventional fractionation, additional time
could reduce efficiency when treating a longer course and
may influence the decision to use the device or not.4 Siva
et al.16 compared the BodyFIX system versus no BodyFIX
system on the volume of tumour motion, finding that the
immobilisation reduced the volume of tumour
displacement by a mean of 83% (P = 0.021). Dahele
et al.17 were the only group to investigate the
immobilisation of the patient without a rigid device for
SBRT, looking at bony anatomy matching. They stated
that when matching to bone, they managed to achieve
84% of fractions being within 1 mm translation and 1.5°
rotation.17 There is little literature available investigating
patient and staff perspective on comfort and ease of use
of the different immobilisation devices.
We examined patients having conventionally
fractionated treatment, with a view to use the most
suitable immobilisation device for both conventionally
fractionated treatments and the implementation of SBRT.
We undertook a comparison of the three indexed
immobilisation devices including a range of relevant
endpoints, to determine which immobilisation device:
minimises inter-fraction and intra-fraction patient
motion; is the most efficient and suitable to use; patients
find acceptable (in terms of comfort and positional
security); staff prefer in terms of reproducibility and ease
of use.
Methods
The research proposal was approved by the Department
of Health WA Human Research Ethics committee and
Sheffield Hallam University Dissertation Management
Group. The additional imaging doses delivered were
approved by the Radiological Council of WA. All study
participants gave written informed consent prior to
participation.
The study was conducted between April 2013 and
November 2014, with patients selected according to the
inclusion and exclusion criteria shown in Table 1.
Patients receiving either thoracic or abdominal
radiotherapy were included as they use the same
immobilisation and both encounter respiratory-associated
tumour motion. Based on previous imaging data, a
sample size of 45 was adequately powered to detect
clinically important differences with 5% significance and
80% power. Forty-eight patients were entered into the
study, although three patients were later removed from
the study due to patient request or a change in treatment.
Forty-five patients were evenly randomised into three
study groups using the ‘sealed envelope’ method. This
method removed sampling bias as the staff were not
aware of the study arms at allocation as these were sealed
blindly in an envelope, prior to booking their
treatment.18
The patients were immobilised supine according to
randomisation: (1) The Q Fix arm shuttle (the
department’s standard immobilisation device for lung and
upper abdomen patients); (2) BodyFIX blubag and (3)
BodyFIX blubag with vacuum wrap. These devices are
shown in Figure 1. The Q Fix arm shuttle is an indexed
chest board system with winged sides to support the
arms, moveable head rest and hand poles. The BodyFIX
is an evacuated vacbag system that shapes to the contour
of the patient. The blubag can also be formed with a
vacuum wrap sealing the patient’s body within the system
under an allocated vacuum pressure up to a maximum of
100 mbar.
All patients were scheduled for 20–36, 1.8–2 Gray
fractions on a 6/18 megavoltage (MV) linear accelerator
with a kilovoltage (kV) imaging system. Orthogonal
images were scheduled daily before and after treatment,
with all isocentre shifts being performed online by the
treating radiation therapists (RTs), assessing spine, carina,
chest wall and ribs for guidance. The images were re-
matched by five suitably trained RTs to examine the
differences between the pre-treatment computed
tomography (CT) to treatment positional changes for
inter-fraction motion and the post-treatment images for
intra-fraction motion.
Table 1. Inclusion and exclusion criteria.
Inclusion: Exclusion:
Patients only allocated to
Varian OBI/ Varian Exactrac
treatment linacs
Paediatric patients
(less than 18 years old)
Any thoracic or abdominal tumour,
treated with radical intent
Patients with intellectual
disability or cognitive
impairment
Patients unable to maintain
their position throughout
treatment
Patients weighing
150 kg or more
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Overall distance was calculated from the co-ordinates
in each direction, using the three-dimensional (3D)
vector (Pythagorean formula for the Euclidean distance in
a 3D space).9,11,19 The effect of distance moved during
treatment was investigated using repeated measures
analysis with linear mixed models. Fixed effects of time,
device and device by time were included in the model as
well as random effect of individual within device. The
response, overall distance, was log transformed for
analysis purposes. All treatments were timed by the RTs
for set up duration (from the time the patient got onto
the bed, into treatment position, until the RTs left the
treatment room) and set down (beam-off time to the
patient getting off the treatment couch). These times were
analysed with a one-way analysis of variance (ANOVA) to
determine whether set up and set down durations
differed across the devices. Summaries of overall distance
are reported as median (and inter-quartile range (IQR))
while times are reported as mean (and standard
deviation).
The patients received a pre-treatment questionnaire at
the CT appointment and a post-treatment questionnaire
on the last fraction to assess how comfortable and secure
they felt in the allocated immobilisation device. These
were given to the researcher anonymously. Staff were
allowed 1 month to complete an anonymous online
satisfaction questionnaire on completion of the study to
gauge their opinions. Both questionnaires had been
assessed for content and validity in a pilot study
undertaken by the BodyFIX-trained team.
Results
Image data analysis
The image data were analysed for 41 of the 45 patients in
this study. Patients 34, 37, 41 and 42 (two from BodyFIX
without wrap and two from BodyFIX with wrap groups)
were removed from analysis due to incomplete data, as
no post-treatment images were taken for these patients
due to differing matching requirements. A summary of
the absolute translations in each direction and overall
distance moved from the planned isocentre to the
treatment isocentre is provided in Table 2. The smallest
overall distance moved was the BodyFIX without wrap
with a median of 4.4 mm (IQR 2.14), whereas the
BodyFIX with wrap had the largest median of 6.6 mm
(IQR 2.27). The absolute translations in each direction
were similar across all devices. The IQR of overall
distance was smaller for the BodyFIX without wrap
suggesting more reliable stabilisation. In comparison,
there were relatively large maximum values for the left-
to-right direction for the arm shuttle and the superior-to-
inferior direction for the BodyFIX with wrap, indicating
some weakness in these devices for these directions.
Differences in overall distance were investigated by
assessing the linear mixed effects model pairwise
Figure 1. Photographs of the three devices (from Left to right): Q-Fix Arm shuttle, BodyFIX without vacuum wrap and BodyFIX with vacuum
wrap.
Table 2. Summary statistics for absolute translations (mm) and
overall distance (mm) by device.
Device Variable N Median IQR Min Max
Arm shuttle Left–right 15 2.18 2.16 0.16 16.34
Superior–inferior 2.31 2.65 1.33 9.77
Anterior–
posterior
2.01 2.57 0.95 5.15
Overall distance 5.25 5.52 2.01 16.49
BodyFIX
without
wrap
Left–right 13 1.87 1.25 0.12 6.27
Superior–inferior 2.55 1.8 0.02 6.6
Anterior–
posterior
2.05 2.34 0.26 4.13
Overall distance 4.38 2.14 2.25 9.21
BodyFIX with
vacuum
wrap
Left–right 13 2.01 1.45 0.31 5.55
Superior–inferior 4.90 5.39 0.3 13.55
Anterior–
posterior
1.95 2.37 0.21 7.51
Overall distance 6.61 2.27 3.09 14.05
IQR, inter-quartile range; Min, minimum; Max, maximum.
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comparisons of device by time point. There were no
significant differences in overall distance for any
comparison of devices within intra-fraction images (all
P > 0.05). However, for inter-fraction motion, the
BodyFIX with wrap was significantly larger in terms of
overall distance moved than both the arm shuttle
(median 8.7 vs. 6.2 mm; P = 0.021) and BodyFIX
without wrap (8.7 vs. 6.0 mm; P = 0.002). Similarly, for
the same comparison within intra-fraction images, there
was no significant difference in inter-fraction overall
distance between the arm shuttle and BodyFIX without
wrap (6.3 vs. 6.0 mm; P = 0.340).
Treatment timings
Summary statistics for set up and set down durations for
each device are provided in Tables 3 and 4. Overall
differences in devices for set up and set down times were
compared using one-way ANOVAs. The BodyFIX with
wrap took significantly longer than both the BodyFIX
without wrap (mean 7.92 vs. 2.23 min; P < 0.001) and the
arm shuttle (7.92 vs. 2.80 min; P < 0.001). Furthermore, it
took significantly longer to set down the BodyFIX with
wrap compared to both the BodyFIX without wrap (1.51
vs. 0.60 min; P < 0.001) and arm shuttle (1.51 vs.
0.60 min; P < 0.001). Conversely, there was no significant
difference between the BodyFIX without the wrap and the
arm shuttle for set up (2.23 vs. 2.80 min; P = 0.185) or set
down (0.60 vs. 0.60 min; P = 0.962).
Patient preferences
The response rate for the pre-treatment questionnaire was
98% (47/48) of patients, with a reduction in the post-
treatment questionnaire response rate to 80% (36/45).
From the pre-treatment questionnaire, the patients were
asked to choose their preferred device, based on the
descriptions in the participant information leaflet. The
results showed that 38% (18/47) would choose the
BodyFIX with wrap.
Staff preferences
The staff questionnaire had a response rate of 63% (42/67).
Eighty one per cent (34/42) of RTs preferred the use of the
BodyFIX without the vacuum wrap. When asked ‘how they
would rate their confidence levels using the bodyFIX
without wrap’, 93% (39/42) reported being confident or
very confident. Conversely, only 50% (21/42) reported
being confident or very confident using the BodyFIX with
the vacuum wrap, with a further 26% (11/42) not being
confident or not very confident. Overall, the RTs preferred
the BodyFIX system’s ability to maintain the patient
position with 69% (29/42) describing the system as good or
excellent, whereas the current immobilisation (arm shuttle)
only had 14% (6/42).
Discussion
We assessed the three candidate immobilisation devices
using several different endpoints. While the devices were
similar for some endpoints, there was a clearly preferred
device overall.
Inter-fraction/intra-fraction stability
The data suggest that the BodyFIX without wrap is the
most effective, and the BodyFIX with wrap the least
effective, device for maintaining patient position.
Although not statistically significant, small differences in
the range of motion and stability of a device might be
clinically important when treating with tighter margins
and hypo-fractionated treatment. The BodyFIX with wrap
had large inter-fraction variations in the superior-to-
inferior direction (see Table 2), which the literature
agrees with this worsening during treatment.4 The
BodyFIX without wrap had the smallest range of
movement and overall maintains the patient position to
millimetre accuracy which is a requirement for
SBRT.16,20,21
Table 3. Summary statistics of overall distance (mm) from mid-point
separated by device and time point.
Time point Group Median IQR Min Max
Pre Arm shuttle 6.25 4.70 3.65 16.20
BodyFIX without wrap 5.96 2.00 4.31 11.28
BodyFIX with wrap 8.72 1.80 6.24 15.01
Post Arm shuttle 1.60 0.70 1.01 2.54
BodyFIX without wrap 1.53 0.60 0.85 2.10
BodyFIX with wrap 1.64 0.30 1.36 2.41
Pre-treatment images equate to inter-fraction motion (from planning
CT to treatment setup), whereas post-treatment images equate to
intra-fraction motion (motion during treatment.). IQR, inter-quartile
range; Min, minimum; Max, maximum.
Table 4. Summary of the set up and set down durations (minutes)
separated by device.
Duration Device N Mean Standard deviation
Set up Arm shuttle 15 2.80 0.95
BodyFIX without wrap 13 2.23 0.49
BodyFIX with wrap 13 7.92 1.32
Set down Arm shuttle 15 0.60 0.22
BodyFIX without wrap 13 0.60 0.30
BodyFIX with wrap 13 1.51 0.36
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The results are comparable by Han et al.7 with the
mean movement being less than 1 mm across all
BodyFIX devices and Wang et al.22 reporting the majority
of intra-fraction errors being less than 3 mm and overall
motion of 1.4 mm using the alpha cradle. These studies
both assessed tumour motion, achieving a high level of
immobilisation, and cannot be directly compared to this
study, but highlight the effectiveness of rigid
immobilization, including the BodyFIX system.7,22
In this study, the post-treatment image results show that
there is minimal intra-fraction movement of the patient.
These differences could have been influenced by the online
shifts performed by the RT matching the images online,
highlighting some minor differences between treating staff
and the five trained image reviewers. There is no statistical
difference between the three devices, which correlates with
the results from other studies, having mean intra-fraction
differences of less than 1 mm for bony anatomy matching
and 3 mm for tumour matching.4,5,16,17,19
Treatment times
The BodyFIX without wrap was the most efficient in terms of
set up duration, but not significantly different from the arm
shuttle. However, when compared to the BodyFIX with wrap,
this difference in set up time is clinically important, as it is
more beneficial to patient comfort. As prolonged treatment
times can increase patient discomfort, reducing the treatment
duration can result in less intra-fractional movement.4,12 The
literature notes a similar pattern with treatment times from
verification to post-treatment cone beam CT (CBCT), with the
vacuum fixation time of 29.40  5.57 min as opposed to
24.17  5.54 for the evacuated cushion only group.5 Winnie
et al.4 demonstrated similar efficiency to this study, with the
evacuated cushion with abdominal compression taking the
longest time of 32.54  8.07 min, the evacuated cushion time
of 29.33  8.20 min and chest board time of
30.17  5.56 min. They also demonstrated higher accuracy in
the evacuated cushion and abdominal compression over the
chest board and evacuated cushion groups, however, as per
this study, was not statistically significant.4 The set up times in
our study were a lot shorter than those of Han et al.7 who used
the BodyFIX with vacuum wrap, taking between 21 and
40 min, however, it was not clearly stated how these times
were measured.
Patient preferences
Patient preference regarding the device they would choose
appears to have been influenced by the immobilisation
device that they were allocated to despite the question
asking ‘from reading the descriptions, which device do
you feel would be most comfortable for you?’. Although
potentially biased it does suggest that patients tolerated a
range of devices. From the responses, there could be a
lack of understanding or lack of reading the participant
information. As the preferences of device were not
statistically significant, it would have been beneficial to
assess the patients’ opinions at pre-treatment, improving
patient understanding and reducing potential bias from
the patients’ options by immobilising them on each
device before their CT appointment, as Han et al.7 did.
In a study by Han et al.,7 21% of patients preferred the
vacuum wrap; however, in this study 30% (14/46)
patients on the study or 88% (14/16) in the BodyFIX
with wrap arm found the BodyFIX with wrap to be
comfortable or very comfortable at the pre-treatment
questionnaire and 33% (13/39) at post-treatment. One
patient (3%) described being uncomfortable in the
BodyFIX with wrap at the post-treatment questionnaire,
which could suggest this patient did not tolerate the
abdominal pressure.7,9 The devices that patients thought
were the most secure and prevented movement tended to
be the BodyFIX without wrap and BodyFIX with vacuum
wrap which in conjunction with the literature, staff
opinions and imaging results suggest that these are strong
accurate immobilisation devices.3,8,23
As patients who were identified as unlikely to maintain
their position during treatment were excluded from entry
on the study, factors including co-morbidities and
difficulty in breathing were not taken into account. One
patient resigned early from the BodyFIX with vacuum
wrap study arm after 20 fractions as they could not
tolerate the vacuum pressure. This could be a problem
for patients with breathing difficulties receiving
radiotherapy for lung cancer.7,9
All devices were accepted by patients and the clinical
benefits of stable immobilisation and the potential to
reduce tumour motion are more likely to outweigh these
small preferences. In our study, any delays in treatment
from day of immobilisation device preparation due to
chemotherapy reduced the effectiveness of the BodyFIX
system as the patient size had changed slightly with
weight loss. Although this may influence the imaging
results, these changes did not require a re-simulation.
Poorly fitting immobilisation, large variations in
treatment verification images and separation changes
would warrant re-simulation. Removing data for four
patients due to lack of post-treatment image data reduced
the effectiveness of the sample size calculation for the
inter- and intra-fraction motion slightly.
Staff preferences
Little literature exists on staff preference, but is worth
consideration when implementing a new immobilisation
ª 2016 The Authors. Journal of Medical Radiation Sciences published by John Wiley & Sons Australia, Ltd on behalf of
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device. The staff questionnaires had a high response rate,
with 81% of staff preferring the use of the BodyFIX
without wrap. The reduced treatment time could
influence the RT’s opinion on the most effective
immobilisation device, in addition to the ease of using
this device. The lower confidence levels of staff when
using the BodyFIX with wrap could have influenced the
decision to choose the BodyFIX without wrap as staff
were more comfortable using this and more confident. As
the study progressed, staff became more familiar with the
different devices and this was highlighted as staff who
had treated more patients had higher confidence levels
than those who had only seen a few. Although training
was given to all staff in the use of the BodyFIX system,
confidence was still low when using the vacuum wrap.
This could have influenced the ability to use the device to
its optimum and therefore decreased the accuracy of the
device.
A key strength of this study was that it was randomised
with a clear method described, which other studies
comparing immobilisation systems did not report,
therefore reducing the risk of bias within the results.8,13
There were also good response rates on questionnaires
from both patients and staff. Further studies could
investigate which device best restricts internal organ
motion and tumour motion, comparing the BodyFIX
blubag alone, BodyFIX system with the vacuum wrap and
the BodyFIX blubag with ACP.
This study was conducted with patients receiving
conventional radiotherapy fractionation rather than
hypo-fractionated SBRT. Daily kV imaging alone,
however, is insufficient to adequately localise a tumour
for SBRT.3,7,24 At the time of this study, daily cone-
beam imaging and other methods to account for
respiratory-induced tumour motion could not be
assessed due to limited resources and staff training.
However, with rapid changes in technology, a drive for
staff training and additional resources, this imaging
modality could be introduced, meeting the Australian
and New Zealand Guidelines for safe practice of
SBRT.24 In addition, higher doses per fraction with
SBRT could mean longer treatment times, which might
in turn influence intra-fraction motion. The ideal
immobilisation device for SBRT remains uncertain.
Conclusion
The BodyFIX without wrap was the device chosen for
clinical implementation as it is a suitable immobilisation
device, is the most efficient in terms of set up time and
was most preferred by staff in terms of accuracy,
efficiency and staff confidence.
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